Temasek's ClavystBio bets on AI to generate 2-3x returns from biotech

Temasek's ClavystBio bets on AI to generate 2-3x returns from biotech

19 December, 2025

biotechnology ClavystBio life sciences Temasek

Printed by Unregistered user on Fri, 19 Dec 2025 16:19:14 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Venture Capital

ClavystBio co-anchors $11.6m funding in healthtech Respiree

SG Digest: ClavystBio partners A*STAR; Keppel part-exits Australia's Ventura

Read more from Singapore

‘Singapore washing’ gains pace as Chinese firms relocate to city-state

Venture Capital

Singapore AI startup Galatek raises $30m Series A